Clinical trials sponsored by Akeso

Phase breakdown

Conditions studied

Recruiting trials led by Akeso

• A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
  NCT07669779 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
  NCT06953999 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
  NCT05859750 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
  NCT06617416 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
  NCT07010263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 53 locations
• A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
  NCT07114315 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• A Study of Ivonescimab in First-Line ES-SCLC
  NCT07245446 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
  NCT06951503 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• AK129 Combination Therapy for Advanced Solid Tumors
  NCT06943820 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
  NCT06928389 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Akeso recruiting for?

Akeso is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.